The present invention is directed to indazole derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions mediated by the CB-1 receptor; more particularly, use in the treatment of disorders and conditions responsive to inverse agonism of the CB-1 receptor. More particularly, the compounds of the present invention are useful in the treatment of metabolic disorders.
本发明涉及
吲唑衍
生物,含有它们的药物组合物以及它们在治疗由CB-1受体介导的疾病和症状中的应用;更具体地,用于治疗对CB-1受体的反向激动作用敏感的疾病和症状。更具体地说,本发明的化合物在治疗代谢性疾病方面是有用的。